Literature DB >> 23989467

The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw--results of a clinical case series with an average follow-up of 20 months.

Philipp Stockmann1, Moritz Burger2, Cornelius von Wilmowsky2, Tobias Ebker2, Rainer Lutz2, Anne Bauersachs2, Emeka Nkenke2, Friedrich Wilhelm Neukam2, Falk Wehrhan2.   

Abstract

OBJECTIVES: The present case series evaluates the success rate of osteotomy and primary wound closure in patients with bisphosphonate-associated osteonecrosis of the jaw (BRONJ).
MATERIALS AND METHODS: Eighty patients suffering from BRONJ were included in the study. All patients received intravenous bisphosphonate therapy and underwent osteotomy and primary wound closure according to a standardised protocol. After discharge, the patients were reviewed on a regular basis over an average time period of 20 months.
RESULTS: During follow-up in 11 patients, a recurrence of BRONJ occurred in the former operation field. Seventeen patients died due to their underlying disease. The success rate of osteotomy and primary wound closure in the treatment of BRONJ was calculated at 84.2 % 20 months after surgery. The results showed non-significant difference concerning the outcome of surgery in the different clinical stages of BRONJ.
CONCLUSIONS: In accordance with previous studies, stage-independent osteotomy and primary wound closure combined with antibiotics shall be deemed a viable treatment option in patients suffering from BRONJ. CLINICAL RELEVANCE: With a high success rate, osteotomy in combination with primary wound closure seems to be a viable alternative to more conservative protocols in the treatment of BRONJ.

Entities:  

Mesh:

Year:  2013        PMID: 23989467     DOI: 10.1007/s00784-013-1092-2

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  19 in total

1.  A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Filippo Moretti; Gian Andrea Pelliccioni; Lucio Montebugnoli; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-10-14

2.  Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.

Authors:  Matteo Scoletta; Paolo G Arduino; Paola Dalmasso; Roberto Broccoletti; Marco Mozzati
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-05-10

3.  Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study.

Authors:  Christoph Pautke; Florian Bauer; Sven Otto; Thomas Tischer; Timm Steiner; Jochen Weitz; Kilian Kreutzer; Bettina Hohlweg-Majert; Klaus-Dietrich Wolff; Sigurd Hafner; Gerson Mast; Michael Ehrenfeld; Stephen R Stürzenbaum; Andreas Kolk
Journal:  J Oral Maxillofac Surg       Date:  2010-10-25       Impact factor: 1.895

4.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

5.  Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis.

Authors:  Alberto Bedogni; Giorgia Saia; Giordana Bettini; Anita Tronchet; Andrea Totola; Giorgio Bedogni; Giuseppe Ferronato; Pier Francesco Nocini; Stella Blandamura
Journal:  Oral Oncol       Date:  2011-03-24       Impact factor: 5.337

6.  Surgical management of bisphosphonate induced osteonecrosis of the jaws.

Authors:  R A Williamson
Journal:  Int J Oral Maxillofac Surg       Date:  2009-12-16       Impact factor: 2.789

7.  Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.

Authors:  Lucio Montebugnoli; Laura Felicetti; Davide Bartolomeo Gissi; Angelo Pizzigallo; Gian Andrea Pelliccioni; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-05-07

8.  Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study.

Authors:  Matteo Scoletta; Paolo G Arduino; Lucia Reggio; Paola Dalmasso; Marco Mozzati
Journal:  Photomed Laser Surg       Date:  2010-04       Impact factor: 2.796

9.  Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

Authors:  Paolo Vescovi; Elisabetta Merigo; Maddalena Manfredi; Marco Meleti; Carlo Fornaini; Mauro Bonanini; Jean Paul Rocca; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2008-02       Impact factor: 2.796

10.  Bisphosphonate-related osteonecrosis of the jaws (Bronj).

Authors:  Francesco Beninati; Riccardo Pruneti; Giuseppe Ficarra
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2013-09-01
View more
  8 in total

1.  Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw.

Authors:  Yoon Ho Kim; Ho Kyung Lee; Seung Il Song; Jeong Keun Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-10-24

Review 2.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

3.  Treatment of Medication-Related Osteonecrosis of the Jaw and its Impact on a Patient's Quality of Life: A Single-Center, 10-Year Experience from Southern Italy.

Authors:  Giacomo Oteri; Gianluca Trifirò; Matteo Peditto; Loredana Lo Presti; Ilaria Marcianò; Francesco Giorgianni; Janet Sultana; Antonia Marcianò
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

4.  Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients.

Authors:  Pelagia I Melea; Ioannis Melakopoulos; Efstathios Kastritis; Christina Tesseromatis; Vasileios Margaritis; Meletios A Dimopoulos; Evangelos Terpos
Journal:  Int J Dent       Date:  2014-06-17

5.  Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies.

Authors:  Tae-Hwan Kim; Won-Gyo Seo; Chul-Hong Koo; Jae-Hoon Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2016-08-24

6.  Clinical characteristics and recurrence-related factors of medication-related osteonecrosis of the jaw.

Authors:  Mong-Hun Kang; Dong-Keon Lee; Chang-Woo Kim; In-Seok Song; Sang-Ho Jun
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2018-10-26

7.  Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo.

Authors:  Manuel Weber; Andi Homm; Stefan Müller; Silke Frey; Kerstin Amann; Jutta Ries; Carol Geppert; Raimund Preidl; Tobias Möst; Peer W Kämmerer; Marco Kesting; Falk Wehrhan
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

8.  Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).

Authors:  Diana Florina Nica; Mircea Riviș; Ciprian Ioan Roi; Carmen Darinca Todea; Virgil-Florin Duma; Cosmin Sinescu
Journal:  Medicina (Kaunas)       Date:  2021-02-05       Impact factor: 2.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.